Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production

This study was to investigate the antidiabetic and antihyperlipidemic effects of (E)-3-[3, 4-dihydroxyphenyl-1-(piperidin-1-yl)prop-2-en-1-one] (36-13) (TS), one of caffeic acid amide derivatives, on high-fat (HF-) fed mice. The C57BL/6J mice were randomly divided into the control (CON) group and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Yueh-Hsiung, Lin, Cheng-Hsiu, Shih, Chun-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130186/
https://www.ncbi.nlm.nih.gov/pubmed/25140189
http://dx.doi.org/10.1155/2014/821569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130186/
https://www.ncbi.nlm.nih.gov/pubmed/25140189
http://dx.doi.org/10.1155/2014/821569

Ejemplares similares